Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Colorectal Neoplasm Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00089401
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 8
Not applicableUnknownNCT03679039
What this trial is testing

A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA

Who this might be right for
Colorectal Cancer With Liver Metastases
Fudan University 100
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT02282722
What this trial is testing

Improving Informed Consent for Palliative Chemotherapy

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic CancerUnresectable Pancreatic Cancer
Dana-Farber Cancer Institute 216
Large-scale testing (Phase 3)Looking for participantsNCT06794086
What this trial is testing

SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Jun Huang 24
Testing effectiveness (Phase 2)UnknownNCT05797883
What this trial is testing

FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Unresectable or Metastatic Colorectal Cancer
China Medical University, China 30
Early research (Phase 1)Ended earlyNCT02408861
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmAnal CarcinomaHIV Infection+7 more
National Cancer Institute (NCI) 79
Large-scale testing (Phase 3)UnknownNCT03125161
What this trial is testing

Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Fudan University 150
Not applicableLooking for participantsNCT05398380
What this trial is testing

Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research

Who this might be right for
Colorectal CancerLiver MetastasesGenetic Change
Hospital Vall d'Hebron 35
Very early researchLooking for participantsNCT07050394
What this trial is testing

A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer RecurrentColorectal Cancer Stage IV
Shanghai Changzheng Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06848842
What this trial is testing

Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Looking for participantsNCT06555133
What this trial is testing

Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

Who this might be right for
Colorectal Carcinoma Metastatic in the Liver
Brown University 18
Not applicableEnded earlyNCT01978249
What this trial is testing

A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis

Who this might be right for
Colorectal Cancer
Yonsei University 52
Testing effectiveness (Phase 2)Study completedNCT03142516
What this trial is testing

FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status

Who this might be right for
Colorectal NeoplasmsColorectal CarcinomaColorectal Cancer Metastatic+1 more
Grupo Espanol Multidisciplinario del Cancer Digestivo 20
Not applicableStudy completedNCT00984048
What this trial is testing

Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jewish General Hospital 160
Early research (Phase 1)Study completedNCT02279433
What this trial is testing

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

Who this might be right for
Solid Tumors
Nuvation Bio Inc. 46
Early research (Phase 1)Looking for participantsNCT06853496
What this trial is testing

Study of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Unresectable Colorectal Neoplasm Metastasis
Eiji Shinozaki 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000305
What this trial is testing

Cetuximabβ Combined With Envolimab and mFOLFOX6 in Subjects With Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Tao Zhang 42
Large-scale testing (Phase 3)UnknownNCT04416854
What this trial is testing

The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer

Who this might be right for
Metastatic Colon CancerSurgery
Fudan University 627
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06218888
What this trial is testing

A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases

Who this might be right for
Colo-rectal Cancer
Fujian Cancer Hospital 17
Next Page